换一批
换一批Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).
作者：
Elizabeth M,Swisher [1]
;
Tanya T,Kwan [2]
;
Amit M,Oza [3]
;
Anna V,Tinker [4]
;
Isabelle,Ray-Coquard [5]
;
Ana,Oaknin [6]
;
Robert L,Coleman [7]
;
Carol,Aghajanian [8]
;
Gottfried E,Konecny [9]
;
David M,O'Malley [10]
;
Alexandra,Leary [11]
;
Diane,Provencher [12]
;
Stephen,Welch [13]
;
Lee-May,Chen [14]
;
Andrea E,Wahner Hendrickson [15]
;
Ling,Ma [16]
;
Prafull,Ghatage [17]
;
Rebecca S,Kristeleit [18]
;
Oliver,Dorigo [19]
;
Ashan,Musafer [20]
;
Scott H,Kaufmann [15]
;
Julia A,Elvin [21]
;
Douglas I,Lin [21]
;
Setsuko K,Chambers [22]
;
Erin,Dominy [2]
;
Lan-Thanh,Vo [2]
;
Sandra,Goble [2]
;
Lara,Maloney [2]
;
Heidi,Giordano [2]
;
Thomas,Harding [2]
;
Alexander,Dobrovic [20]
;
Clare L,Scott [23]
;
Kevin K,Lin [2]
;
Iain A,McNeish [24]
作者单位：
University of Washington, Seattle, WA, USA. swishere@uw.edu.
[1]
Clovis Oncology, Inc., Boulder, CO, USA.
[2]
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
[3]
BC Cancer-Vancouver, Vancouver, BC, Canada.
[4]
GINECO, Centre Léon Bérard and University Claude Bernard, Lyon, France.
[5]
Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
[6]
The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
[7]
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[8]
University of California Los Angeles, Los Angeles, CA, USA.
[9]
The Ohio State University, James Cancer Center, Columbus, OH, USA.
[10]
Gustave Roussy Cancer Center and INSERM U981, Villejuif, France.
[11]
l'Université de Montréal (CHUM), Montréal, QC, Canada.
[12]
Lawson Health Research Institute, London, ON, Canada.
[13]
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
[14]
Mayo Clinic, Rochester, MN, USA.
[15]
Rocky Mountain Cancer Centers, Lakewood, CO, USA.
[16]
Tom Baker Cancer Center, Calgary, AB, Canada.
[17]
Guy's and St. Thomas NHS Foundation Trust, London, UK.
[18]
Stanford University Cancer Center and Stanford Cancer Institute, Palo Alto, CA, USA.
[19]
University of Melbourne Department of Surgery, Austin Hospital, Heidelberg, VIC, Australia.
[20]
Foundation Medicine, Inc., Cambridge, MA, USA.
[21]
University of Arizona Cancer Center, Tucson, AZ, USA.
[22]
Royal Melbourne Hospital and Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
[23]
Imperial College London, London, UK.
[24]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);BRCA1蛋白质(BRCA1 Protein);BRCA2蛋白质(BRCA2 Protein);DNA甲基化(DNA Methylation);DNA结合蛋白质类(DNA-Binding Proteins);女(雌)性(Female);人类(Humans);吲哚类(Indoles);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);卵巢肿瘤(Ovarian Neoplasms);铂(Platinum);启动区, 遗传(Promoter Regions, Genetic)
DOI
10.1038/s41467-021-22582-6
PMID
33941784
发布时间
2022-03-02
- 浏览4
Nature communications
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
